Market Capitalization (Millions $) |
0 |
Shares
Outstanding (Millions) |
44 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-4 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
American Cryostem Corporation
American CryoStem Corporation is a biotechnology company specializing in the development and commercialization of adipose tissue-based stem cell products and services. The company operates a state-of-the-art FDA registered and cGMP compliant laboratory facility where it stores, processes, and cryopreserves adipose-derived stem cells for both therapeutic and research applications.
American CryoStem's main offering is its proprietary Adipose-Derived Mesenchymal Stem Cells (ADSCs), which have potential therapeutic applications in regenerative medicine and personalized healthcare. These stem cells can be used to treat various medical conditions, including orthopedic injuries, cardiovascular diseases, and autoimmune disorders. The company also offers services for the collection, processing, and storage of adipose tissue and stem cells.
In addition to its stem cell products and services, American CryoStem also provides educational and training programs to healthcare professionals interested in incorporating stem cell therapies into their practice. The company aims to advance the field of regenerative medicine by promoting ethical and responsible use of stem cells and supporting research and development efforts.
Overall, American CryoStem Corporation is a leading company in the field of adipose tissue-based stem cell technology, offering innovative products, services, and educational programs to advance the potential benefits of stem cell therapy in various medical applications.
Company Address: 1 Meridian Road Eatontown 7724 NJ
Company Phone Number: 747-1007 Stock Exchange / Ticker: CRYO
|